Conference Coverage

Anticoagulation not routinely needed after TAVR: ADAPT-TAVR

Publish date: April 4, 2022

 

A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

Surgical groups push back against new revascularization guidelines
Federal Practitioner
Similar 10-year survival after CABG, PCI in heavy calcification
Federal Practitioner
What does a pig-to-human heart transplant mean for medicine?
Federal Practitioner
‘Incomprehensible’ CABG recommendation raises concerns
Federal Practitioner
No amount of alcohol safe for the heart: WHF
Federal Practitioner
New data explore risk of magnetic interference with implantable devices
Federal Practitioner
Death of pig heart transplant patient is more a beginning than an end
Federal Practitioner
Congress opens investigation into FDA’s handling of a problematic heart device
Federal Practitioner
New HF guidelines feature ‘quad’ therapy, tweaked terminology
Federal Practitioner
FDA approves leadless, single-chamber pacemaker system
Federal Practitioner